BOSTON, Sept. 29, 2020 (GLOBE NEWSWIRE) -- TearClear announces the appointment of industry veteran Robert Bailey to the company's Board of Directors. Mr. Bailey brings over two decades of leadership experience in the Ophthalmology industry having served on the executive teams as General Counsel/Chief Legal Officer for Allergan and Bausch + Lomb."We welcome Bob's leadership, judgment and industry expertise to our Board," said TearClear Chief Executive Officer Robert Dempsey. "His extensive M&A and Public Markets experience will be a tremendous asset as we seek to advance the ...Full story available on Benzinga.com